OSTEOSARCOMA
Clinical trials for OSTEOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new OSTEOSARCOMA trials appear
Sign up with your email to follow new studies for OSTEOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug hope for young bone cancer patients
Disease control TerminatedThis study looked at whether the drug cabozantinib can help children, teens, and young adults with a type of bone cancer called osteosarcoma that cannot be fully removed by surgery. Participants took cabozantinib pills daily along with standard supportive care, or received suppor…
Matched conditions: OSTEOSARCOMA
Phase: PHASE2 • Sponsor: Ipsen • Aim: Disease control
Last updated May 16, 2026 23:48 UTC
-
Experimental combo for advanced bone cancer shows early promise, but trial halted
Disease control TerminatedThis early-phase trial tested a combination of two drugs—TQB2928 injection and anlotinib capsules—in 20 people with advanced bone cancer (osteosarcoma) or other solid tumors that had returned or spread. The goal was to see if the combination could slow tumor growth or shrink tumo…
Matched conditions: OSTEOSARCOMA
Phase: PHASE1 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 15, 2026 11:54 UTC